13F-HR/A filed by Versant Venture Management, LLC
Versant Venture Management, LLC filed this 13F-HR/A for the quarter ended 2014-12-31, filed 2015-04-22, with 6 holding rows worth $113,697,981.
- Accession
- 0001104659-15-029151
- Filer
- CIK 1560009
- Filed
- 2015-04-22
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2014
A holdings report, amendment of type restatement, 6 entries on the cover page, a total value of $113,697,981 stated on the cover page (in dollars after the unit check, H1), rows summing to $113,697,981 with VALUE read as dollars, detected, 13F file number 028-16849. A later restatement replaced it, so the quarter does not use it. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CLOVIS ONCOLOGY INC | 189464100 | COM | 814,833 | $60,485,054 | dollars, detected | |
| FIVE PRIME THERAPEUTICS INC. | 33830X104 | Common Stock | 1,092,152 | $24,955,673 | dollars, detected | |
| ACHAOGEN INC | 004449104 | COM | 1,281,152 | $12,504,044 | dollars, detected | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 1,048,601 | $7,256,319 | dollars, detected | |
| INOGEN INC | 45780L104 | COM | 155,284 | $4,967,535 | dollars, detected | |
| KYTHERA BIOPHARMACEUTICALS I | 501570105 | COM | 70,376 | $3,529,356 | dollars, detected |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-15-025167 | superseded | 2015-04-02 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001104659-15-029151 | this filing | 2015-04-22 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001104659-15-029709 | base | 2015-04-23 | acceptance time not in the bulk data set |